[ORGANIZATION]
Los Angeles Institute for Metabolic Research
Featured in 1 tracked story · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
274 clusters · 1023 sources · last updated
Latest: Retatrutide shows significant weight loss in diabetes clinical trials
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr